Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
2,943
Views
1
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial

Jia-Wei Xua Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaView further author information
,
Bu-Sen Wangb Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of ChinaView further author information
,
Ping Gaoc Logistics University of Chinese People’s Armed Police Force, Tianjin, People’s Republic of ChinaView further author information
,
Hai-Tao Huangd CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Fei-Yu Wangd CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Wei Qiua Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaView further author information
,
Yuan-Yuan Zhanga Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaView further author information
,
Yu Xud CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Jin-Bo Goud CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Lin-Ling Yue Expanded Program on Immunization, Yubei District Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaView further author information
,
Xuan Liud CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Rui-Jie Wangd CanSino Biologics Inc., Tianjin, People’s Republic of ChinaView further author information
,
Tao Zhud CanSino Biologics Inc., Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Li-Hua Houb Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Qing- Wanga Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2281355 | Received 27 Apr 2023, Accepted 04 Nov 2023, Published online: 30 Dec 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.